A Drug-Drug Interaction (DDI) Study of HDM1002 With Rifampicin and Itraconazole in Healthy Subjects
Clinical trial NCT06562088 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06562088
- Sponsor
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-16
- Primary completion
- 2024-11-19
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.